insights_auto
Why is MBIO down 2,44%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
US$0,40
arrow_downward
-2,44%(-0,010) 1D
US$0,40
arrow_upward
+1,15% (+0,0046)bedtimeAfter hours
Closed: 9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
US$0,43
High
US$0,43
Low
US$0,38
Mkt. cap
3,01 ລ້ານ
Avg. vol.
29,09 ພັນ
Volume
99,18 ພັນ
52-wk high
US$1,80
52-wk low
US$0,38
EPS
US$-0,46
Beta
2,09
Shares outstanding
6,73 ລ້ານ
No. of employees
4
Open
US$0,43
High
US$0,43
Low
US$0,38
Mkt. cap
3,01 ລ້ານ
Avg. vol.
29,09 ພັນ
Volume
99,18 ພັນ
52-wk high
US$1,80
52-wk low
US$0,38
EPS
US$-0,46
Beta
2,09
Shares outstanding
6,73 ລ້ານ
No. of employees
4
News stories
From web sources and news partners
Yahoo Finance
·
1 ຊົ່ວໂມງກ່ອນ
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
24/7 Wall St.
·
15 ຊົ່ວໂມງກ່ອນ
Why "VOO and Chill" Lost Money for 8 Straight Years: What $100,000 in the S&P 500 Did From 2000 to 2008
Investor's Business Daily
·
7 ຊົ່ວໂມງກ່ອນ
Futures: 6 Stocks Near Buy Points; Big Earnings, Inflation Data Due
Seeking Alpha
·
9 ຊົ່ວໂມງກ່ອນ
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websitemustangbio.com